Cognoptix
Marlborough, Massachusetts, United States
Cognoptix is developing an affordable, non-invasive screening test patients can take at their doctor’s office. The key to effective preventive therapy and treatment of Alzheimer’s is the creation of an “early warning system” for the disease, before it progresses to the point where treatment options are limited. Cognoptix’ technology has demonstrated successful early clinical results as the company develops its diagnostic platform, which consists of a laser eye scanning device combined with an ophthalmic ointment which specifically identifies Alzheimer’s-related proteins found in the lens of the eye.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2002
- Website
- cognoptix.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Cognoptix?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now